Recurrent Implantation Failure (RIF) — Causes, Workup & Treatment

Medically reviewed by Dr. Shweta Agarwal, MBBS, DGO. Last updated: June 2026.

Information on this page is educational and does not replace a medical consultation. Outcomes depend on individual clinical factors.

What is RIF — and is it the same as recurrent miscarriage?

No — RIF and recurrent pregnancy loss (RPL) are two different situations, and it matters clinically which one you are dealing with.

RIF describes the situation in which embryos that appear to be of good quality have been transferred on multiple occasions without ever establishing a clinical pregnancy. Definitions vary between centres and guidelines — some use a set number of failed transfers, others focus on the number of chromosomally normal (euploid) embryos transferred without success. Because the definition varies between centres and guidelines, your doctor will assess your history individually. The shared territory with RPL — some uterine and immune investigations overlap — does not make them the same condition, and the treatment focus differs. If your situation involves confirmed pregnancies that have then been lost, please see our recurrent pregnancy loss page.

RIF is one of the more emotionally wearing experiences in fertility treatment. The grief of a cycle that "worked" as far as the laboratory is concerned, yet produced nothing — no test line, no scan — is particular and real. Acknowledging this is the starting point of care.

In Marathi, this is sometimes described as वारंवार रोपण अपयश — the same phrase your doctor may use when explaining what the investigations are looking for.

Why do good embryos fail to implant? Embryo-related causes

Embryo morphology — how an embryo looks under the microscope — is an imperfect measure of quality. An embryo that scores well visually can still carry chromosomal abnormalities that prevent implantation. This is not a laboratory error; it is a fundamental biological reality.

Chromosomal aneuploidy The most important embryo-related cause of failed implantation is chromosomal abnormality (aneuploidy). The rate of aneuploidy in embryos increases with age, but is present at all ages. A chromosomally abnormal embryo will not implant, or will implant briefly before being lost. Pre-implantation genetic testing for aneuploidy (PGT-A) — testing the embryo's chromosomes before transfer — identifies which embryos are chromosomally normal (euploid) and selects only those for transfer. This is a key strategy in managing the embryo-quality component of RIF.

Embryo development and blastocyst culture Extended embryo culture to the blastocyst stage (day 5 or 6) allows further selection — embryos that do not reach blastocyst in culture are less likely to have implanted in the uterus. Blastocyst culture is standard practice in a well-equipped IVF laboratory. At Aansh Hospital, the IVF laboratory is directed by Aayush Agarwal, Ph.D., Senior Clinical Embryologist, who oversees culture conditions, equipment, and embryo selection.

Sub-optimal laboratory conditions Culture media quality, incubator consistency, and embryologist technique affect embryo development in ways that are not visible to the eye. After repeated failures, requesting an independent review of embryo development records or seeking a second-opinion cycle is appropriate.

Why do good embryos fail to implant? Uterine and endometrial causes

For implantation to succeed, the uterine lining (endometrium) must be in the right state at the right time, and the uterine cavity must be free of mechanical obstacles.

Uterine cavity abnormalities Endometrial polyps, a uterine septum, submucous fibroids, or intrauterine adhesions (Asherman's syndrome) can all physically impair an embryo from implanting or from developing normally in the early days after transfer. These should be excluded by hysteroscopy — a direct camera examination of the cavity — before a full RIF workup is considered complete. Many cavity problems found on hysteroscopy are correctable in the same procedure. See also uterine cavity conditions for detail on each.

Thin or poorly prepared endometrium A thin endometrial lining at the time of transfer is associated with lower implantation rates. Causes include previous uterine surgery (curettage), Asherman's syndrome, or poor blood supply to the uterus. Protocols to optimise a thin lining are discussed on an individual basis with Dr. Shweta Agarwal.

The window of implantation (WOI) and endometrial receptivity The endometrium is receptive to an embryo only during a brief, specific window — typically around days 19–23 of a 28-day cycle, or approximately five to seven days after progesterone starts in a frozen transfer cycle. In some women, this window is shifted earlier or later than expected, meaning a standard transfer timing misses it.

A test called the endometrial receptivity analysis (ERA) — a genomic test on a small endometrial biopsy taken at the expected implantation window — can determine whether the endometrium is in a receptive or non-receptive state at the standard timing. If the window is displaced, the next transfer can be scheduled at the adjusted, personalised time. ERA is most useful after two or more failed transfers of euploid embryos where other causes have been excluded. It is not a routine first-line test for all IVF patients. Dr. Shweta Agarwal can explain whether ERA is indicated in your case during a consultation.

Chronic endometritis A low-grade, often symptom-free bacterial infection of the endometrial lining — chronic endometritis — has been linked to implantation failure in several studies. It is diagnosed on endometrial biopsy with special immunostaining. When confirmed, a course of targeted antibiotics can resolve it, and this is a potentially reversible and treatable cause worth excluding in the RIF workup.

Hydrosalpinx Fluid from a damaged, blocked fallopian tube can drain back into the uterine cavity and is toxic to embryos. If a hydrosalpinx is identified, the tube is usually surgically removed (salpingectomy) or occluded before an IVF transfer cycle — this is a standard step, not optional. A hysteroscopy and pelvic ultrasound will identify this.

Why do good embryos fail to implant? Other contributing factors

Immunological and thrombophilic factors — where the evidence is mixed Several immune-related mechanisms have been proposed in RIF, including elevated or aberrant uterine natural killer (uNK) cells, abnormal cytokine environments, and antiphospholipid syndrome (APS). APS — an established, treatable cause — should be tested (antiphospholipid antibody panel, confirmed on two occasions twelve weeks apart). Low-dose aspirin and heparin during the transfer cycle is the standard treatment when APS is confirmed.

Other immune "add-on" therapies — such as intralipid infusion, prednisolone, G-CSF, and others — are used in some centres but have limited, mixed, or inconclusive evidence of benefit in unselected patients. NICE (UK) and ESHRE guidance currently do not recommend them as routine for all RIF patients. At Aansh Hospital, immune add-ons are discussed individually, with honest framing of the current evidence, not as standard protocol.

Sperm DNA fragmentation Elevated sperm DNA fragmentation can impair embryo development in the earliest days after fertilisation, even when embryo morphology appears normal. A sperm DNA fragmentation test is a reasonable addition to the male-factor component of the workup. ICSI uses a single selected sperm; physiological ICSI (PICSI/IMSI) techniques that select morphologically superior sperm may be discussed where fragmentation is high.

Lifestyle factors Smoking, excess alcohol, extremes of body weight, and poorly controlled systemic conditions (thyroid disorders, diabetes) can impair endometrial receptivity and early embryo development. Thyroid function (TSH, anti-TPO antibodies) is a standard part of the workup. Lifestyle optimisation is always a worthwhile parallel step.

What does a structured RIF investigation workup look like?

Not all investigations are indicated for every couple. The workup is sequenced based on what has already been done, the number and type of transfers, and your individual history. A structured approach typically covers:

Dr. Shweta Agarwal will not run every test on this list for every patient. The workup is built around your history, the quality and number of previous transfers, and what has already been excluded.

How is RIF managed? Correction of identified causes

Management in RIF is individualised — there is no single protocol that suits everyone, because causes differ. Treatment is directed at whatever the workup identifies:

• Cavity abnormalities found → hysteroscopic correction — polyps, septum, adhesions, and submucous fibroids can often be corrected in the same procedure, after which a transfer cycle is planned.
• Aneuploidy as a likely driver → PGT-A — chromosomal testing of embryos before transfer selects euploid embryos, removing the single most common embryo-side cause of failed implantation.
• Displaced window of implantation → ERA-guided personalised embryo transfer — transfer timing is adjusted to match the individual woman's receptive window. Requires a mock (no-embryo) cycle for the biopsy first.
• Chronic endometritis confirmed → targeted antibiotics — a course directed by the organisms found; a repeat biopsy may confirm resolution before transfer.
• Hydrosalpinx found → salpingectomy or occlusion, followed by IVF transfer.
• APS confirmed → low-dose aspirin and heparin during the transfer cycle.
• Thin endometrium → individualised endometrial preparation protocol, planned with Dr. Shweta Agarwal based on your history.
• Elevated sperm DNA fragmentation → ICSI, PICSI/IMSI, antioxidant supplementation, lifestyle modification.
• No cause found → honest conversation — sometimes investigations yield no clear answer. This is more common than patients expect. Continuing with euploid embryo transfers, endometrial optimisation, and supportive monitoring remains a reasonable path. Many couples with unexplained RIF do achieve a pregnancy in a subsequent cycle.

The cost of a RIF workup and subsequent treatment varies by the investigations required and the treatment path. Final cost depends on individual clinical evaluation — see Costs & EMI for current pricing.

What does "no cause found" mean for your chances?

It is important to be honest about this: a thorough workup does not always identify a clear, fixable cause. When investigations are normal and embryos are euploid, RIF becomes more difficult to explain, but it does not become hopeless. A significant proportion of couples with unexplained RIF go on to achieve a successful IVF pregnancy in a subsequent cycle. Optimising the endometrium, using euploid embryos, and maintaining close clinical oversight are all meaningful steps even without a named cause.

Unproven or experimental "add-on" therapies marketed directly to patients — growth hormone, platelet-rich plasma (PRP), assisted hatching in standard cases, and others — are offered at some private clinics. The current evidence for most of these in unselected RIF patients is either inconclusive or absent. They should not be considered standard of care, and their costs can be substantial. A frank, evidence-based conversation about what is and is not supported is part of good RIF care.

When should you ask for a RIF-focused review?

Consider requesting a structured RIF review — rather than simply booking another transfer — if any of the following apply:

• You have had two or more IVF transfers without a clinical pregnancy (positive test/ultrasound) and no systematic investigation has been done.
• You have had two or more failed transfers of chromosomally normal (euploid, PGT-A tested) embryos.
• Your previous centre has not offered a hysteroscopy, ERA assessment, or immune screening as part of the workup.
• You want an independent assessment of embryo development records and laboratory quality.
• You are exhausted and need someone to map out what comes next.

A consultation with Dr. Shweta Agarwal and the embryology team at Aansh Hospital provides a structured review of your records, a tailored investigation plan, and an honest conversation about what each result would mean for next steps. You can begin a fertility assessment or contact us directly — details below.